The week at Retraction Watch featured the heartfelt response of a researcher when she found out a paper she’d reviewed had been retracted, and a new member of our leaderboard. Here’s what was happening elsewhere:
While we are often among the first to chuckle at a good sting of a predatory publisher, there have probably been enough of them by now to have made the point. And even Ottawa Citizen reporter Tom Spears — whose stings have been among the most hilarious — seems to agree. He didn’t want to … Continue reading For this fake editorial, “merit of artistic writing” was enough for publication
In November, a vice president at an institution in Taiwan retracted a hotly debated cancer paper from Nature Cell Biology, citing image problems including duplications. Now, the Journal of Biological Chemistry has done the same, again citing image duplications. There are a few things to note about the latest retraction: One, the last author is again Kuo … Continue reading Prominent researcher in Taiwan loses another paper for image duplication
The final week of 2016 at Retraction Watch featured the retraction of a high-profile paper on diabetes from Harvard, and the retraction of a JAMA article on whether zinc was useful for the common cold. Here’s what was happening elsewhere:
A pathology journal is retracting two papers after an investigation at the last author’s institution in Germany found evidence of scientific misconduct. The notice for both papers cites an investigation involving Regine Schneider-Stock, who studies cancer biology at the Friedrich Alexander-University Erlangen-Nuremberg (FAU). Meanwhile, another 2005 paper that lists Schneider-Stock as the first author was retracted … Continue reading Cancer researcher in Germany loses multiple papers after misconduct finding
On December 15, we removed a post from view as a result of a law that some have misused to have content removed from the web. Today, we have reinstated that post. Here’s what the post about, if you’re curious:
Journals published by the European Molecular Biology Organization (EMBO) have retracted a handful of figures in two papers with the same last and first authors. After some figures in the 2005 and 2007 papers were flagged on PubPeer and the authors couldn’t provide the original data, the journals decided to retract parts of the papers, … Continue reading EMBO journals retract figures in two papers missing source data
2013 probably felt like it was going to be a great year for stem cell biologist Douglas Melton at Harvard. He had published a buzz-worthy paper in Cell about a new way to potentially boost insulin in diabetics, attracting significant media attention, and eventually gathering nearly 200 citations. But 2016 is closing out on a less … Continue reading Harvard biologist retracts diabetes breakthrough in Cell
This week at Retraction Watch featured revelations about a frequent co-author of the world’s retraction record holder, and a prison term for fraud. Here’s what was happening elsewhere:
It has been a tough couple of years for surgeon Paolo Macchiarini, once lauded for pioneering a groundbreaking procedure to transplant tracheas. After a series of documentaries prompted his former employer, Karolinska Institutet (KI), to reopen a misconduct investigation against him, KI has today released one verdict regarding a 2014 Nature Communications paper: guilty. KI said … Continue reading Karolinska requests retraction of 2014 Macchiarini paper